Senior Carer - Must be face to face medication administration trained.
Search Consultancy are working with a large provider of care for vulnerable service users with various support needs to source a number of experienced Senior Carers in West Yorkshire.
The emphasis of this job will be supporting young adults in their daily activities and caring for them.
Study treatments will be sent to participants' homes by post.
About the Trial: Our Client is conducting a significant clinical trial to investigate the effects of oral semaglutide versus placebo on cardiovascular outcomes in up to 20,000 participants with type 2 diabetes.
Participants will take part remotely by completing questionnaires on their own devices or during telephone interviews with research nurses.
At Halcyon Health & Social Care, we are looking for reliable and compassionate support workers to work with multiple services across Barnsley that help adults and children in the following settings:
Being a support worker, you will be making a difference every day by helping people to live their lives to the fullest, regardless of their situation or ability.
A bonus of agency work is the flexibility and variety that's open to you; at Halcyon, we also understand the importance of having a work-life balance.
Social Worker Learning Disabilities and Transitions Leeds City Council
We are looking for a Social Worker with current Social Work experience to join a busy front door team.
You would have the opportunity to work in partnership with people in Leeds with learning disabilities and their carers and a range of other professionals and colleagues, including health and provider organisations.
Position Overview: Reed are proud to be working a leading institution in clinical research in their search for junior doctors to assist in a clinical trial.
Participants take part remotely (by completing questionnaires on their own device or during telephone interviews with research nurses) and study treatment is sent to their homes by post.
The trial seeks to investigate the effect of oral semaglutide vs. placebo on cardiovascular outcomes in up to 20,000 participants with type 2 diabetes.